Nyrada
Menu
NYR:
Market Cap:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Our Science
Cardiovascular
Neuroprotection
Inflammation/Pain
Autoimmune
Technical Glossary
Publications
Investors
Investor Welcome
ASX Announcements
News
Presentations
Share Price Information
Key Dates
Investors Glossary
Corporate Governance
Media
Financial Reports
Half Yearly Reports
Newsletters
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
News
Presentations
Share Price Information
Key Dates
Investors Glossary
Corporate Governance
Media
Financial Reports
Half Yearly Reports
Newsletters
ASX Announcements
25-May-2020
Milestone Achieved in the Nyrada Brain Injury Program
30-Apr-2020
Nyrada Preclinical Program & Corporate Update Presentation
27-Apr-2020
Change of Director's Interest Notice - JM
22-Apr-2020
Appointment of New Chief Financial Officer
20-Apr-2020
Preclinical Program & Corporate Update Global Webinar
14-Apr-2020
Appendix 4C - March 2020 quarterly
6-Apr-2020
Nyrada Newsletter Released
16-Mar-2020
Update on Progress in Nyrada Programs
27-Feb-2020
Nyrada Inc. Corporate Presentation February 2020
25-Feb-2020
Appendix 4D and Half Year Accounts
11-Feb-2020
Significant advance in Nyrada PCSK9i program published
20-Jan-2020
Nyrada Inc - Chairman's letter to shareholders
20-Jan-2020
Becoming a substantial holder
17-Jan-2020
Nyrada Inc - Corporate Presentation
16-Jan-2020
NOX: Listing of Nyrada Inc. spin-off on ASX
16-Jan-2020
NYR Commences Trading on the ASX
16-Jan-2020
Becoming a substantial holder
16-Jan-2020
Becoming a substantial holder
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
15-Jan-2020
Regulation S-Foreign Ownership Restrictions
14-Jan-2020
Confirmation and Waiver under ASX Listing Rules
14-Jan-2020
Pre-Quotation Disclosure
14-Jan-2020
Updated Pro-forma - Financial Position and Commitments
14-Jan-2020
Securities Trading Policy
14-Jan-2020
Capital Structure and Restricted Securities
14-Jan-2020
Financial Statements Year End 30 June 2019
14-Jan-2020
Financial Statements Year End 30 June 2018
14-Jan-2020
Corporate Governance Statement
14-Jan-2020
Equity Incentive Plan
14-Jan-2020
Amended and Restated Certificate of Incorporation and Bylaws
14-Jan-2020
Supplementary Prospectus
14-Jan-2020
Prospectus
14-Jan-2020
Appendix 1A, Information Form and Checklist, Annexure 3
14-Jan-2020
Distribution Schedule
14-Jan-2020
Top 20 Securityholders
14-Jan-2020
ASX Market Release - Admission and Quotation
